The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9062043, Table 20b, Compound 28 ID: ALA3703937
PubChem CID: 58485097
Max Phase: Preclinical
Molecular Formula: C19H13ClN4O2
Molecular Weight: 364.79
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1cc2c(Nc3cccc(Cl)c3)nc3cc(C(=O)O)ccc3c2cn1
Standard InChI: InChI=1S/C19H13ClN4O2/c20-11-2-1-3-12(7-11)23-18-14-8-17(21)22-9-15(14)13-5-4-10(19(25)26)6-16(13)24-18/h1-9H,(H2,21,22)(H,23,24)(H,25,26)
Standard InChI Key: PCNHIHDEJGRLDW-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
2.3383 -1.3500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2982 3.7531 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2960 5.2539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5925 6.0085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5873 7.5085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2856 8.2540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0108 7.4995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0521 8.0959 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-0.0056 5.9995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2991 3.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1962 3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1962 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4975 3.7477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5359 3.1462 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.4996 4.9477 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
11 13 2 0
13 7 1 0
5 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 15 1 0
20 21 2 0
21 4 1 0
21 22 1 0
22 23 2 0
23 2 1 0
17 24 1 0
24 25 2 0
24 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.79Molecular Weight (Monoisotopic): 364.0727AlogP: 4.46#Rotatable Bonds: 3Polar Surface Area: 101.13Molecular Species: ACIDHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.21CX Basic pKa: 7.17CX LogP: 2.25CX LogD: 1.83Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.46Np Likeness Score: -0.80
References 1. (2015) Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators,